Prediction of cancer-associated venous thromboembolism
Recruiting
- Conditions
- Cancer-associated venous thromboembolism
- Registration Number
- NL-OMON23071
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 2000
Inclusion Criteria
Adult patients (age >18 years)
-Ambulatory setting
-Histologically or cytologically confirmed cancer
-Chemotherapy indicated within 3 months
Exclusion Criteria
-Desmoid tumors
-Pre-stages of cancer
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Venous thromboembolism in the 6 months following cancer diagnosis
- Secondary Outcome Measures
Name Time Method -Venous thromboembolism in 12 months and longer follow-up periods after cancer diagnosis.<br>-Venous thromboembolism in the 6 months, 12 months and longer follow-up periods after reactivation of cancer.<br>-Arterial thromboembolism in 6 months, 12 months and longer follow-up periods after primary cancer diagnosis or reactivation of cancer.<br>-Mortality in 6 months, 12 months, and longer follow-up periods after primary cancer diagnosis.